Alto Neuroscience, Inc. (ANRO)
(Delayed Data from NYSE)
$3.89 USD
-0.14 (-3.47%)
Updated Oct 31, 2024 04:00 PM ET
After-Market: $3.90 +0.01 (0.26%) 6:54 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ANRO 3.89 -0.14(-3.47%)
Will ANRO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ANRO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANRO
Alto Neuroscience (ANRO): Strong Industry, Solid Earnings Estimate Revisions
ANRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ANRO
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Notable analyst calls this week: McDonald's, Apple and Enphase Energy among top picks
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names